NCT06875050

Brief Summary

This randomized controlled clinical trial included 60 pediatric patients with cystic fibrosis (CF) assigned randomly into two arms; Arm 1(extra care arm):received a tailored dietary plan following Mediterranean diet to cover macronutrients needs according to recommended daily allowance (RDA) for age, with antioxidant supplements in specific doses in oral liquid form (200 mg vitamin E, 300 mg vitamin C, 90 μg Se, 500 μg vitamin A, 30 mg zinc, 3 mg copper and 2000 IU vitamin D) for 6 months. Arm 2: recieved tailored dietary plan following Mediterranean diet as Arm 1 with fat soluble vitamins supplementation (150 μg vitamin A, 2000 IU vitamin D, 100 mg vitamin E and 1000 μg vitamin K) for 6 months. This study aimed to evaluate the effect of antioxidants supplementation on the level of oxidative stress, as measured by 3-Nitrotyrosine, bacterial colonization and diseases severity among CF children.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 12, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 13, 2025

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

March 8, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 13, 2025

Completed
Last Updated

March 13, 2025

Status Verified

March 1, 2025

Enrollment Period

11 months

First QC Date

March 8, 2025

Last Update Submit

March 12, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • evaluate the effect of antioxidants supplementation on the level of oxidative stress among CF children..

    To evaluate the effect of antioxidants supplementation on the level of oxidative stress, as measured by 3-Nitrotyrosine, bacterial colonization and diseases severity among CF children.

    6 months

Study Arms (2)

Arm 1(Extra care group)

EXPERIMENTAL
Other: Mediterranean dietDietary Supplement: Antioxidant Supplement

Arm 2

ACTIVE COMPARATOR
Other: Mediterranean dietDietary Supplement: Fat soluble vitamins supplementation

Interventions

Tailored dietary plan following Mediterranean diet to cover macronutrients needs according to recommended daily allowance (RDA) for age

Arm 1(Extra care group)Arm 2

Fat soluble vitamins supplementation (150 μg vitamin A, 2000 IU vitamin D, 100 mg vitamin E and 1000 μg vitamin K).

Arm 2
Antioxidant SupplementDIETARY_SUPPLEMENT

Antioxidant supplements in specific doses in oral liquid form (200 mg vitamin E, 300 mg vitamin C, 90 μg Se, 500 μg vitamin A, 30 mg zinc, 3 mg copper and 2000 IU vitamin D).

Arm 1(Extra care group)

Eligibility Criteria

Age6 Months - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patients with documented diagnosis of cystic fibrosis (CF) who were diagnosed according to CF Foundation guidelines based upon positive sweat tests and/or the presence of a mutation in the homozygous state or two heterozygous mutations on the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) protein

You may not qualify if:

  • Patients with current pulmonary exacerbations.
  • Patients with severe sepsis.
  • Patients with comorbid systemic illnesses.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain Shams University

Cairo, 1181, Egypt

Location

MeSH Terms

Conditions

Cystic Fibrosis

Interventions

Diet, Mediterranean

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System DiseasesLung DiseasesRespiratory Tract DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesInfant, Newborn, Diseases

Intervention Hierarchy (Ancestors)

Diet, Plant-BasedDiet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of pediatrics

Study Record Dates

First Submitted

March 8, 2025

First Posted

March 13, 2025

Study Start

March 12, 2024

Primary Completion

February 13, 2025

Study Completion

March 1, 2025

Last Updated

March 13, 2025

Record last verified: 2025-03

Locations